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Summary
 
Maturation of immature CD4
 
2
 
CD8
 
2
 
 (DN) thymocytes to the CD4
 
1
 
CD8
 
1
 
 (DP) stage of de-
velopment is driven by signals transduced through a pre–T cell receptor (TCR) complex,
whose hallmark is a novel subunit termed pre-T
 
a
 
 (pT
 
a
 
). However, the precise role of pre-
TCRs in mediating the DN to DP transition remains unclear. Moreover, progress in under-
standing pre-TCR function has been hampered thus far because previous attempts to demon-
strate expression of pT
 
a
 
-containing pre-TCRs on the surface of normal thymocytes have been
unsuccessful. In this report, we demonstrate for the first time that pT
 
a
 
-containing pre-TCR
complexes are expressed at low levels on the surface of primary thymocytes and that these pre-
TCR complexes comprise a disulfide-linked pT
 
a
 
–TCR-
 
b
 
 heterodimer associated not only
with CD3-
 
g
 
 and -
 
e
 
, as previously reported, but also with 
 
z
 
 and 
 
d
 
. Interestingly, while CD3-
 
d
 
is associated with the pre-TCR complex, it is not required for pre-TCR function, as evi-
denced by the generation of normal numbers of DP thymocytes in CD3-
 
d
 
–deficient mice. The
fact that any of the signaling components of the pre-TCR are dispensable for pre-TCR func-
tion is indeed surprising, given that few pre-TCR complexes are actually expressed on the surface
of primary thymocytes in vivo. Thus, pre-TCRs do not require the full array of TCR-associ-
ated signaling subunits (
 
g
 
, 
 
d
 
, 
 
e
 
, and 
 
z
 
), possibly because pT
 
a
 
 itself possesses signaling capabilities.
 
M
 
aturation of immature thymocytes from the CD4
 
2
 
CD8
 
2
 
 (DN)
 
1
 
 to the CD4
 
1
 
CD8
 
1
 
 (DP) stage of de-
velopment requires productive rearrangement of the gene
segments encoding TCR-
 
b
 
 (1–3). The fidelity with which
TCR-
 
b
 
 gene rearrangement has occurred is thought to be
assessed using a surrogate receptor complex termed the
pre-TCR, which is defined by a novel 33-kD pre-T
 
a
 
(pT
 
a
 
) subunit (4). Upon productive rearrangement of
TCR-
 
b
 
, the pre-TCR complex transduces signals through
CD3 (and possibly also pT
 
a
 
) that direct allelic exclusion at
the TCR-
 
b
 
 locus and promote maturation of DN thy-
mocytes to the DP stage (5); however, the molecular details
of how pre-TCR complexes discriminate between aberrant
and productive 
 
b
 
 gene rearrangements remain unclear.
Progress towards a deeper understanding of pre-TCR
complex function is hampered by the absence of a precise
description of pre-TCR subunit composition. At present,
the pre-TCR complex is thought to consist of a disulfide-
linked pT
 
a
 
–TCR-
 
b
 
 (pT
 
a
 
–
 
b
 
) heterodimer associated with
an inadequately defined complement of signaling molecules
(5). Indirect support for the presence of particular TCR–
CD3 chains within the pre-TCR complex comes from
gene-targeted mice, which reveal that the DN to DP tran-
sition is attenuated by elimination of TCR-
 
b
 
, pT
 
a
 
, or
TCR-
 
z
 
 alone, or by simultaneous elimination of CD3-
 
g
 
/
 
d
 
/
 
e
 
(2, 6–8). Direct biochemical analysis of pre-TCR composi-
tion has yielded only incomplete and contradictory results,
particularly regarding the CD3-
 
d
 
 and TCR-
 
z
 
 subunits,
possibly because of the idiosyncrasies of thymic lymphoma
lines used in these analyses (4, 9–11). These discrepancies
could be resolved, if it were possible to analyze pre-TCR
structure using normal primary thymocytes; however, thus
far, attempts to do so have been unsuccessful (4, 12).
This study comprises a rigorous biochemical analysis of
surface TCR expression that clarifies these issues. We pro-
 
1
 
Abbreviations used in this paper:
 
 2D NR
 
3
 
R, two-dimensional nonreduc-
ing 
 
3
 
 reducing; CD3-
 
d
 
0
 
, CD3-
 
d
 
–deficient; DN, CD4
 
2
 
CD8
 
2
 
 double
negative; DP, CD4
 
1
 
CD8
 
1
 
 double positive; HRP-Av, horseradish perox-
idase–conjugated streptavindin; pT
 
a
 
, pre-T
 
a
 
; pT
 
a
 
–
 
b
 
, pT
 
a
 
–TCR-
 
b
 
;
TCR-
 
a
 
0
 
, TCR-
 
a
 
–deficient.
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vide the first demonstration that pT
 
a
 
-containing pre-TCR
complexes are actually expressed at low levels on the sur-
face of normal thymocytes in vivo; moreover, we have
defined their subunit composition. They consist of a disul-
fide-linked pT
 
a
 
–
 
b
 
 heterodimer associated not only with
CD3-
 
g
 
/
 
e
 
 as was previously thought, but also with TCR-
 
z
 
and CD3-
 
d
 
. In addition, we demonstrate that pre-TCR
function is not attenuated in CD3-
 
d
 
–deficient (CD3-
 
d
 
0
 
)
mice (13). Thus, while CD3-
 
d
 
 is a pre-TCR component,
it is not required for pre-TCR function.
 
Materials and Methods
 
Animals.
 
Mice lacking TCR-
 
a
 
 expression (TCR-
 
a
 
0
 
) due to
gene targeting (2, 14) were obtained from The Jackson Labora-
tory (Bar Harbor, ME) and then maintained in our colony. CD3-
 
d
 
0
 
 mice were generated as previously described (13). Production
of TCR-
 
a
 
0
 
CD3-
 
d
 
0
 
, and TCR-
 
a
 
0
 
CD3-
 
d
 
1
 
 mice was achieved
by intercrossing the F1 progeny of a TCR-
 
a
 
0
 
 
 
3
 
 CD3-
 
d
 
0
 
 mating
and then screening F2 mice by Southern blot as previously de-
scribed (15).
 
Cell Lines and Antibodies.
 
The DP 
 
a
 
/
 
b
 
-TCR
 
1
 
 thymic lym-
phoma VL3-3M2 (obtained from Dr. C. Guidos, Hospital for
Sick Children, Toronto, Canada) and a spontaneous thymic lym-
phoma from SCID mice, SL-12 (TCR
 
2
 
; reference 16) were
maintained in RPMI supplemented as previously described (17).
The following mAbs were used: anti–TCR-
 
b
 
 (H57-597); anti–
CD3-
 
g
 
/
 
e
 
 (7D6); and anti–TCR-
 
a
 
 (H28-710). The following
polyclonal rabbit Abs were used: anti–TCR-
 
z
 
 (551; reference
17); anti-CD3-
 
d
 
 (R9; gift of Dr. Lawrence Samelson, National
Institutes of Health [NIH], Bethesda, MD); and anti-pT
 
a
 
. The
anti-pT
 
a
 
 Ab was raised against a GST (glutathione-S-transferase)
fusion protein encompassing the cytoplasmic domain of pT
 
a
 
 as
previously described (17).
 
Plasmid Construction.
 
The pT
 
a
 
 cDNA was cloned by per-
forming reverse transcriptase–PCR on total RNA from day 15
fetal thymocytes (gift of Dr. Paul Love, National Institute of Child
Health and Human Development [NICHD], Bethesda, MD) us-
ing standard methodology (15). First, strand cDNA was synthe-
sized using the Superscript Preamplification System (GIBCO BRL,
Bethesda, MD), and then the pT
 
a
 
 cDNA was amplified by PCR
(MJ Research, Inc., Watertown, MA) using primers flanking the
coding region. The resultant fragment was cloned into pCR2.1
(Invitrogen, San Diego, CA) and verified by automated sequenc-
ing in our facility. The pT
 
a
 
 cytoplasmic tail–GST fusion protein
was generated by PCR amplification of the pT
 
a
 
 cDNA using
primers that appended SmaI and EcoRI linkers onto the cytoplas-
mic tail fragment. The fragment was ligated into pCR2.1, excised
using SmaI and EcoRI, and directionally cloned in frame into
pGEX-2T (Pharmacia Biotech Inc., Piscataway, NJ). After trans-
formation into BL21pLysS cells, expression of the pT
 
a
 
 cyto-
plasmic tail–GST (glutathione-S-transferase) fusion protein was
induced, after which it was purified from bacterial extracts using
glutathione-Sepharose (Pharmacia Biotech Inc.) according to the
manufacturer’s recommendations (18).
A 1.1-kb XhoI-XbaI cDNA fragment encoding the TCR-
 
b
 
subunit of the 2B4 TCR (pCDMB–2B4-
 
b; provided by Dr. Juan
Bonifacino, NICHD, Bethesda, MD) was subcloned into the pXS
expression vector (gift of Dr. Juan Bonifacino) using standard
methodology (15).
Transfection. pXS–2B4-b and the neomycin resistance plas-
mid pFneo were linearized with HindIII and EcoRI, respectively,
and then transfected into SL-12 SCID thymic lymphoma cells by
electroporation (300 V, 400 mFa) using a BTX electroporation
unit (BTX, Inc., San Diego, CA). Clones that were resistant to
G418 (Boehringer Mannheim, Indianapolis, IN) were analyzed
for TCR-b expression by flow cytometry.
Biotin Labeling, Immunoprecipitation, and Electrophoresis. Biotin
surface labeling, after which cell viability was consistently .98%,
was performed as previously described (17, 18). Cell lysis, immu-
noprecipitation, and electrophoresis were as previously described
(17, 18). Electrophoretically separated surface-biotinylated pro-
teins were transferred to membranes and visualized with horse-
radish peroxidase–conjugated streptavidin (HRP-Av; Southern
Biotechnology Associates, Inc., Birmingham, AL) as previously
described (17).
Recapture Assay. Recapture assays were performed as previ-
ously described (17) using the anti-pTa Ab. The resultant immune
complexes were resolved either on two- or one-dimensional
nonreducing SDS-PAGE gels, after which the surface-labeled pro-
teins were visualized as above.
Flow Cytometry. Flow cytometry was performed as previously
described (18).
Results
Expression of pTa-containing Pre-TCR Complexes on the
Surface of Primary Thymocytes. It is well established that
immature thymocytes express surface TCR complexes con-
taining TCR-b without TCR-a; however, it remains un-
clear whether these complexes comprise TCR-b homo-
dimers or, alternatively, heterodimers of TCR-b and pTa,
the hallmark of the pre-TCR complex (4, 12, 19). This is-
sue remains unresolved because previous attempts to dem-
onstrate expression of pTa-containing pre-TCR complexes
on the surface of primary thymocytes have been unsuccess-
ful (4, 12, 19). Consequently, we wished to determine if
pTa-containing pre-TCR complexes were actually ex-
pressed on the surface of primary thymocytes. Thymocytes
from TCR-a0 mice were used because they lack a/b-TCR
complexes which might otherwise complicate analysis of
pre-TCR structure, yet they still exhibit normal pre-TCR
function (2, 14). Detergent extracts of surface biotin–labeled
Figure 1. Expression of pTa-containing pre-TCR complexes on the
surface of primary thymocytes. Surface biotin–labeled thymocytes from
TCR-a0 mice were solubilized in Brij 96, immunoprecipitated with
anti–TCR-b Ab (H57-597; right), or control hamster IgG (left) and re-
solved on 2D NR3R SDS-PAGE gels. Surface-labeled proteins were
visualized by HRP-Av and chemiluminescence. Migration positions of
individual subunits are indicated.1463 Berger et al.
thymocytes were immunoprecipitated either with control
hamster IgG or with an anti–TCR-b mAb after which the
resultant immune complexes were resolved by two-dimen-
sional nonreducing 3 reducing (2D NR3R) SDS-PAGE
(Fig. 1). The anti–TCR-b mAb immunoprecipitation
contained associated CD3-g/e heterodimers as well as
disulfide-linked pTa–b heterodimers. Curiously, neither
surface-labeled TCR-z nor CD3-d was visible. Thus, primary
thymocytes do indeed express surface pre-TCR complexes
in which pTa–b and CD3-g/e heterodimers are evident.
The apparent absence of CD3-d and TCR-z from
pre-TCR complexes does not exclude them as potential
pre-TCR components, as subunit visibility in this assay is
dependent upon accessibility during surface labeling. Ac-
cordingly, proteins that did not label efficiently would be
missed, providing an inaccurate view of pre-TCR subunit
composition. In particular, surface-labeled TCR-z mole-
cules were conspicuously absent from a/b-TCR complexes
expressed by the VL3-3M2 thymic lymphoma (Fig. 2 A),
despite the fact that these a/b-TCR complexes do contain
TCR-z (data not shown). Likewise, our inability to iden-
tify labeled CD3-d subunits in the pre-TCRs expressed by
primary thymocytes may result from inefficient biotin-labeling
of CD3-d and/or from comigration with a contaminating
protein that obscures CD3-d.
Recapture Assay for Analyzing Pre-TCR Composition.
To circumvent the limitations outlined above, we used a
coimmunoprecipitation strategy to rigorously determine the
subunit composition of the pre-TCR complex. A subunit
was deemed part of the pre-TCR complex if Abs reactive
with that subunit coprecipitated surface-labeled pTa, the
hallmark of the pre-TCR complex. Coimmunoprecipitated
pTa molecules were identified using the recapture assay,
which occurs in three phases (Fig. 2 A, top): (a) Ab reactive
with TCR subunits were used to coimmunoprecipitate pTa
molecules (if associated) from cell extracts made with de-
tergents selected for their ability to maintain the noncova-
lent interactions between subunits; (b) noncovalent interac-
tions were disrupted by boiling the immune complex in
1% SDS; and (c) coimmunoprecipitated pTa–b hetero-
dimers were identified by using anti-pTa Abs to recapture
them from among the SDS-solubilized proteins. To verify
that the anti-pTa Abs specifically recaptured pTa–b het-
erodimers, the recapture assay was performed on anti–
TCR-b immunoprecipitates from both a/b-TCR–expres-
sing (VL3-3M2) and pre-TCR–expressing (SL-12b.12)
thymic lymphoma cells (Fig. 2 A, bottom). Parallel anti–
TCR-b immunoprecipitates were resolved on 2D NR3R
SDS-PAGE gels to reveal the protein composition of the
original immunoprecipitation. In the anti–TCR-b immu-
noprecipitations from pre-TCR1 cells, heterodimers of
pTa–b and CD3-g/e were evident, whereas in those from
a/b-TCR1 cells, we observed heterodimers of TCR-a
and -b in association with CD3-g/d/e, but not pTa (Fig.
2 A, bottom left). The anti-pTa Ab recaptured pTa–b het-
erodimers from pre-TCR–expressing SL-12b.12 cells, but
not from cells expressing only a/b-TCR complexes (VL3-
3M2; Fig. 2 A, bottom center), demonstrating that the recap-
ture assay specifically identifies pTa–b heterodimers. This
was also evident in a similar experiment in which the sam-
ples were resolved on one-dimensional gels in which the
interchain disulfide bonds between pTa and TCR-b were
maintained (Fig. 2 B).
Composition of Pre-TCR Complexes Expressed on the Surface
of Primary Thymocytes. Having established that the recap-
ture assay was specific, we next wished to evaluate subunit
composition of pre-TCR complexes expressed on the sur-
face of primary thymocytes. Abs reactive with TCR-b,
CD3-g/e, TCR-z, and CD3-d coprecipitated pTa–b het-
erodimers from detergent extracts of surface-labeled thy-
mocytes (Fig. 3 A). Thus, according to the above definition,
our analysis demonstrates that the pre-TCR complexes ex-
pressed by primary thymocytes in vivo comprise pTa–b
heterodimers associated with CD3-g/d/e, and TCR-z.
Figure 2. pTa–b heterodimers
are specifically recaptured by Abs
reactive with the cytoplasmic do-
main of pTa. (A) Recapture assay.
Recapture assay is schematized in
the top panel. (Bottom) Brij 96
detergent extracts of surface-
labeled  VL3-3M2 and SL-12b.12
cells were immunoprecipitated
with anti–TCR-b. After elution
by boiling in SDS, the anti–
TCR-b immune complexes
were quenched with NP-40 and
split into three equal parts which
were either: (a) held on ice; (b)
immunoprecipitated with anti-
pTa Ab; or (c) immunoprecipi-
tated with control rabbit IgG.
The samples were then resolved on 2D NR3R SDS-PAGE gels, after
which the surface-labeled proteins were visualized with HRP-Av and
chemiluminescence. (B) Anti-pTa Ab specifically recaptured pTa–b
heterodimers from detergent extracts of surface-labeled pre-TCR1 (SL-
12b.12) but not from a/b-TCR1 (VL3-3M2) cells. A recapture assay was
performed as above except that the samples were resolved on one-dimen-
sional SDS-PAGE under nonreducing conditions.1464 Composition of Pre-TCR Complexes Expressed on Primary Thymocytes
To determine if CD3-g/e, CD3-d, and TCR-z were all as-
sociated with pTa–b within the same complex, we per-
formed a series of sequential immunoprecipitations to see if
all of the pTa–b heterodimers could be depleted from the
detergent extracts by exhaustive preclearing using Abs reac-
tive with those proteins (Fig. 3 B). Indeed, virtually all of
the pTa–b heterodimers expressed on the surface of TCR-
a0 thymocytes could be precleared using Abs reactive with
either CD3-g/e or -d. In contrast, anti–TCR-z Ab was
able to preclear only z50% of the pTa–b heterodimers,
indicating that either z is associated with only half of the
pre-TCR complexes expressed by primary thymocytes or,
alternatively, that z association with the pre-TCR is weak.
We favor the latter interpretation because z association
with the pre-TCR complex, unlike that of the other pre-
TCR subunits, was easily disrupted by solubilization in
harsh detergents (data not shown). Taken together, these
data demonstrate that all pre-TCR complexes expressed on
the surface of primary thymocytes in vivo contain pTa–b
heterodimers associated with CD3-g/d/e, and of these at
least half are also associated with TCR-z.
Loss of CD3-d Does Not Affect Development of Thymocytes
from the DN to the DP Stage. Since we had demonstrated
CD3-d was a component of the pre-TCR complex, it was
important to determine if d were critical to pre-TCR func-
tion. Thus, we analyzed TCR-a0CD3-d0 mice to deter-
mine if the loss of the CD3-d signaling component affected
pre-TCR expression as well as two manifestations of pre-
TCR function, thymic cellularity and maturation of DN thy-
mocytes to the DP stage (5, 6). Thymocytes from TCR-
a0CD3-d0 mice expressed surface pre-TCRs comprising
pTa–b heterodimers associated with CD3-g/e and TCR-z,
indicating that CD3-d deficiency does not prevent assembly
and surface expression of the remaining pre-TCR subunits
(Fig. 4, A and B, and data not shown). Likewise, d defi-
ciency did not attenuate pre-TCR function. Flow cyto-
metric analysis of thymocytes from TCR-a0CD3-d1 and
TCR-a0CD3-d0 mice revealed that each contained 96%
DP thymocytes (Fig. 4 B). Furthermore, total thymic cellu-
larity in TCR-a0CD3-d0 mice was equivalent to that in
TCR-a0CD3-d1 mice (2.80 3 108 versus 3.31 3 108, re-
spectively; P ,0.01). Thus, the absence of CD3-d from the
pre-TCR complex does not adversely affect the progres-
sion of immature thymocytes from the DN to the DP stage
of development, demonstrating that CD3-d is not neces-
sary for pre-TCR function.
Discussion
Progress in understanding the molecular details of how
the pre-TCR regulates early thymocyte development has
been hampered by the absence of a precise description of
pre-TCR subunit composition. This report addresses this
problem. We provide the first demonstration that primary
thymocytes express pTa-containing pre-TCR complexes
on the cell surface and we have elucidated their subunit
composition. They consist of pTa–b heterodimers associ-
ated not only with CD3-g/e as was previously thought,
but also with TCR-z and CD3-d subunits. Finally, we
found that despite being a component of the pre-TCR,
CD3-d is dispensable for the biological role of the pre-
TCR complex.
Before our study, it was unclear whether the TCR-b
Figure 3. Subunit composition of pre-TCR complexes expressed by
primary explanted thymocytes. (A) Digitonin extracts of biotin–labeled
TCR-a0 thymocytes were immunoprecipitated using Abs reactive with
the following subunits: TCR-b (H57-597), CD3-g/e (7D6), CD3-d (R9)
or TCR-z (551). SDS eluates of the resultant immune complexes were
either resolved directly on SDS-PAGE gels under nonreducing condi-
tions (Total) or after neutralization and immunoprecipitation with either
anti-pTa (pTa) or control rabbit IgG (rIgG). Control anti–TCR-a Ab
did not coprecipitate pTa–b heterodimers from TCR-a0 thymocytes
(data not shown). (B) CD3-g/d/e and TCR-z are all associated with pTa–b
heterodimers within the same pre-TCR complex. Digitonin extracts of
biotin–labeled TCR-a0 thymocytes were either immunoprecipitated di-
rectly with anti–TCR-b or after the detergent extracts had been depleted
of CD3-d, -g/e, or -z with Abs reactive with those proteins. Surface-labeled
proteins were visualized by HRP-Av and chemiluminescence.1465 Berger et al.
complexes (without TCR-a) that were expressed on de-
veloping thymocytes contained TCR-b homodimers or,
alternatively, disulfide-linked pTa–b heterodimers, the hall-
mark of the pre-TCR complex (4, 12, 19). Moreover, be-
cause of previous failures to demonstrate surface expression
of pTa in vivo, it was proposed that pre-TCR complexes
evaluate TCR-b protein structure not through interactions
with an extracellular ligand at the cell surface, but rather
from the cell interior (5), possibly during subunit assembly
within the endoplasmic reticulum. Consistent with this
viewpoint, a TCR-b transgene lacking the variable domain
is able to allelically exclude endogenous TCR-b rearrange-
ment and promote the DN to DP transition, both hall-
marks of pre-TCR function (20). Moreover, analysis of the
efficiency with which TCR-b transgenic DN precursors
differentiate to the DP stage suggests that this transition is
not constrained by a limiting number of intrathymic “niches”
or extracellular ligands, as is true of the antigen-driven se-
lection events that promote maturation of DP thymocytes
to the CD41 or CD81 stage (21). Thus, if pre-TCR com-
plexes do evaluate the fidelity of TCR-b gene rearrange-
ment by interacting with an extracellular ligand, then that
ligand does not absolutely require the TCR-b variable do-
main, nor is it present in limiting quantities. While we pro-
vide the first compelling demonstration that primary thy-
mocytes express pTa-containing pre-TCR complexes on
the cell surface (Figs. 1 and 3), this does not rule out the
possibility that pre-TCR complexes might function from
the cell interior.
Previous analyses of pre-TCR structure were consistent in
indicating that pre-TCRs contained pTa, TCR-b, CD3-g,
and CD3-e; however, there were conflicting data regard-
ing CD3-d and TCR-z (4, 9–11). CD3-d was found to be
a component of pre-TCR complexes in some tumor lines,
but not in others (9, 10). Furthermore, TCR-z association
with the pre-TCR has been implicated by functional crite-
ria but not by physical association (11). These discrepancies
might result either from idiosyncrasies of the lymphoma
cell lines used or from the experimental conditions (9–11).
In particular, the detergent used in cell lysis can markedly
affect association of individual subunits with the pre-TCR.
We found that association of TCR-z with the pre-TCR
complex could be more easily disrupted by lysis in harsh
detergents than that of CD3-g/d/e (data not shown). This
was not true for z association with the a/b-TCR complex
(data not shown). Finally, while we have elucidated the sub-
unit composition of pre-TCRs expressed by TCR-a0 thy-
mocytes, this population consists primarily of DP thymo-
cytes and so it remains possible that distinct subpopulations
of DN thymocytes might express alternative forms of the
pre-TCR complex. Experiments are currently in progress
to investigate this possibility.
The ability of TCR and pre-TCR complexes to trans-
duce signals resides in their invariant CD3-g/d/e and
TCR-z subunits. While both receptors carry the same ar-
ray (g, d, e, and z), the requirements of these receptors for
individual signaling subunits differ (Fig. 5), raising the fun-
damental question of whether the different subunits sub-
serve redundant or unique roles in receptor function. If
CD3-g/d/e and TCR-z subunits are redundant and func-
tion to amplify signals, then it is surprising that the pre-
TCR complex can tolerate the loss of CD3-d, given that
surface expression levels of the pre-TCR complex are so
low (Figs. 1 and 4). In that regard, the pre-TCR may be
able to tolerate loss of CD3-d because pre-TCR signals
need not be as quantitatively intense or because pre-TCRs
have a lower signaling threshold (than a/b-TCR com-
plexes). In support of the latter possibility, pre-TCR com-
plexes function before expression of surface molecules that
can be inhibitory, such as CD4, which we have shown can
decrease signaling competence of the a/b-TCR on DP
thymocytes by sequestering p56lck protein tyrosine kinase
(22). It is also possible that the individual CD3-g/d/e and
TCR-z signaling subunits perform unique functions. Con-
sistent with this hypothesis, it has been shown that immu-
noreceptor tyrosine-based activation motifs of different sig-
naling subunits are able to interact with different cytoplasmic
signaling effector molecules and induce phosphorylation of
different substrates (23). Finally, it is possible that pre-TCR
complexes can tolerate loss of CD3-d because in the ab-
Figure 4. The CD3-d deficiency
does not attenuate the DN to the DP
transition. (A) The absence of CD3-d
does not affect pre-TCR expression.
Digitonin extracts of surface biotin–
labeled TCR-a0CD3-d0 thymocytes
were immunoprecipitated with anti–
CD3-g/e or anti–CD3-d Abs after
which the resultant immune complexes
were analyzed by recapture assay. Im-
mune complexes were resolved by
one-dimensional SDS-PAGE under
nonreducing conditions. The absence
of any recaptured pTa–b hetero-
dimers in the anti–CD3-d immuno-
precipitations demonstrates the speci-
ficity of the anti–CD3-d Ab. (B)
Thymocytes from both TCR-a0CD3-d1 and TCR-a0CD3-d0 mice have the same percentage of CD41CD81 cells (top) and express similar levels of
TCR-b on the cell surface (bottom; thick line), as measured by flow cytometry with fluorochrome conjugated mAbs. The thin line represents control staining
with anti–human CD3-e Ab. The mean number of cells per thymus for each strain is indicated at the bottom of the figure.1466 Composition of Pre-TCR Complexes Expressed on Primary Thymocytes
sence of CD3-d the pTa subunit itself is also able to func-
tion as a signaling subunit. Murine pTa has a cytoplasmic
tail of z30 amino acids which contains consensus motifs for
phosphorylation by protein kinase C and for docking of
SH3 domain containing proteins (12); however, the func-
tional importance of these motifs is unclear as there is little
sequence conservation between the cytoplasmic tails of the
murine and human pTa homologues (5). Recently, the
role of the cytoplasmic tail of pTa was tested by reconstitu-
tion of pTa-deficient mice with a pTa transgene lacking
the cytoplasmic tail (24). While tailless pTa compensated
for pTa deficiency, it did so only partially, leaving open
the possibility that the cytoplasmic tail of pTa does func-
tion as a signaling domain within the pre-TCR complex
and might underlie the pre-TCR’s ability to tolerate loss of
the CD3-d subunit. In that regard it would be informative to
analyze the function of pre-TCR complexes in CD3-d0
thymocytes expressing tailless pTa molecules.
In summary, this study not only provides the first dem-
onstration that pTa-containing pre-TCRs are expressed
on the surface of primary thymocytes in vivo, but also pro-
vides a precise description of pre-TCR subunit composi-
tion. Contrary to previous reports, we found that pre-TCR
complexes contained the CD3-d subunit, but, importantly,
did not require CD3-d to fulfill their biological role in reg-
ulating early thymocyte development. Curiously, loss of
CD3-d does interfere with function of the a/b-TCR com-
plex (13), illustrating that while both receptors possess the
same array of TCR signaling components (g, d, e, and z),
their dependence on individual subunits differs. A deeper
understanding of how individual signaling subunits func-
tion in the pre-TCR and a/b-TCR complexes must await
the generation of new strains of transgenic mice bearing
signaling subunits with mutated immunoreceptor tyrosine-
based activation motifs.
Figure 5. Schematic of the role of the pre-TCR in thymocyte devel-
opment. After b gene rearrangement, immature thymocytes express sur-
face pre-TCR complexes comprising pTa–b heterodimers associated
with CD3-g/d/e and TCR-z signaling subunits. Pre-TCR complexes
are thought to regulate development of thymocytes from the DN to the
DP stage by evaluating the status of the TCR-b protein product after b
gene rearrangement. The molecular interactions underlying this evalua-
tion process are currently unclear; however, development is blocked by
elimination of pTa, TCR-z or CD3-g/d/e, but not CD3-d. Curiously,
elimination of CD3-d does impair the ability of the a/b-TCR to signal
maturation of DP thymocytes to the CD41 or CD81 stage. Thus, while
both pre-TCR and TCR complexes possess the same array of signaling sub-
units, they exhibit differential dependence on the individual components.
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